Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Zhili Song"'
Autor:
Chunhui Luo, Karin Hansson, Zhili Song, Debbie Ågren, Ewa Sjöqvist Persson, Fredrik Cederholm, Changji Xuan
Publikováno v:
Alloys, Vol 2, Iss 4, Pp 321-343 (2023)
Integrated computational materials engineering (ICME) is emerging as an increasingly powerful approach to integrate computational materials science tools into a holistic system and address the multiscale modeling challenges in the processing of advan
Externí odkaz:
https://doaj.org/article/2a57b5f1de674e2083a56d8c679f66ab
Publikováno v:
Applied Sciences, Vol 13, Iss 17, p 9876 (2023)
At the onset of their flight careers, novice pilots often lack clarity regarding the standard attention-allocation pattern. Therefore, to enhance the efficiency of initial flight training, it is crucial for students to develop a comprehensive underst
Externí odkaz:
https://doaj.org/article/ec3140edb7fb4170a37bdac4bb7240bb
Autor:
Chen Zhu, Zhili Song, Anlai Wang, Srimathi Srinivasan, Guang Yang, Rita Greco, Joachim Theilhaber, Elvis Shehu, Lan Wu, Zhi-Yong Yang, Wilfried Passe-Coutrin, Alain Fournier, Yu-Tzu Tai, Kenneth C. Anderson, Dmitri Wiederschain, Keith Bahjat, Francisco J. Adrián, Marielle Chiron
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Isatuximab is a monoclonal antibody targeting the transmembrane receptor and ectoenzyme CD38, a protein highly expressed on hematological malignant cells, including those in multiple myeloma (MM). Upon binding to CD38-expressing MM cells, isatuximab
Externí odkaz:
https://doaj.org/article/c6c673aa2cd34bed8e6c98d6ee4b2379
Publikováno v:
Journal of Lipid Research, Vol 52, Iss 6, Pp 1265-1271 (2011)
Apolipoprotein CIII (apoCIII), a major constituent of triglyceride-rich lipoprotein, has been proposed as a key contributor to hypertriglyceridemia on the basis of its inhibitory effects on lipoprotein lipase. Many immunochemical methods have been de
Externí odkaz:
https://doaj.org/article/aab0bf7dbe6d4441be42eb8ba450d9e8
Autor:
Daniel R Caffrey, Juan Zhao, Zhili Song, Michael E Schaffer, Steven A Haney, Romesh R Subramanian, Albert B Seymour, Jason D Hughes
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e21503 (2011)
Small interfering RNAs (siRNAs) are routinely used to reduce mRNA levels for a specific gene with the goal of studying its function. Several studies have demonstrated that siRNAs are not always specific and can have many off-target effects. The 3' UT
Externí odkaz:
https://doaj.org/article/80e4e30b2ce941189f40e0e34dd04ae8
Autor:
Btissam Chami, Makoto Okuda, Morvarid Moayeri, France Pirenne, Yoko Hidaka, Ashok Nambiar, Zhili Song, Olivier Bedel, Bailin Zhang, Joern Hopke, Gejing Deng, Chen Zhu, Sandrine Macé, Marielle Chiron, Francisco Adrian, Taro Fukao, Frank G. Basile, Thomas Martin
Publikováno v:
Transfusion. 62:2334-2348
There are two FDA-approved anti-CD38 monoclonal antibodies for treatment of multiple myeloma: isatuximab and daratumumab. Owing to expression of CD38 on reagent red blood cells (RBCs), these antibodies interfere with indirect antiglobulin tests (IATs
Publikováno v:
Modeling of systems and processes. 15:35-44
With the increase in the number of vehicles, the number of conflict situations between pedestrians and cars increases - the number of accidents increases. The study of walking behavior and the relationship of behavior with the location of pedestrian
Autor:
Francisco J. Adrian, Marielle Chiron Blondel, Chen Zhu, Xueyan Chen, Srimathi Srinivasan, Elvis Shehu, Jonathan R. Fromm, Celine Nicolazzi, Gang Zheng, Zhili Song, Anlai Wang
Supplementary data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d88bb88858ea1f14c32ea3500bd8f389
https://doi.org/10.1158/1535-7163.22520799
https://doi.org/10.1158/1535-7163.22520799
Autor:
Francisco J. Adrian, Marielle Chiron Blondel, Chen Zhu, Xueyan Chen, Srimathi Srinivasan, Elvis Shehu, Jonathan R. Fromm, Celine Nicolazzi, Gang Zheng, Zhili Song, Anlai Wang
This study reports the pharmacologic effects of isatuximab, a CD38 mAb, on T- and B-cell acute lymphoblastic leukemia (ALL). We analyzed CD38 expression in 50-T-ALL and 50 B-ALL clinical samples, and 16 T-ALL and 11 B-ALL cell lines. We primarily foc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04ecc42ccab581989a39fcfdd73f408f
https://doi.org/10.1158/1535-7163.c.6542781
https://doi.org/10.1158/1535-7163.c.6542781
Autor:
Edward Seung, Zhen Xing, Lan Wu, Ercole Rao, Virna Cortez-Retamozo, Beatriz Ospina, Liqing Chen, Christian Beil, Zhili Song, Bailin Zhang, Mikhail Levit, Gejing Deng, Andrew Hebert, Patrick Kirby, Aiqun Li, Emma-Jane Poulton, Rita Vicente, Audrey Garrigou, Peter Piepenhagen, Greg Ulinski, Michele Sanicola-Nadel, Dinesh S. Bangari, Huawei Qiu, Lily Pao, Dmitri Wiederschain, Ronnie Wei, Zhi-yong Yang, Gary J. Nabel
Publikováno v:
Nature. 603:328-334
Effective antitumour immunity depends on the orchestration of potent T cell responses against malignancies